Frontiers in public health · 2026
The development and psychometric evaluation of vaccine hesitancy and perception scale towards COVID-19 vaccination (VHAPS-CV19).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meiklejohn Amanda L, Teni Mintesnot T, Kalinowski Megan, Poirier Michael, Subramaniam Divya S
Аннотация
The purpose of this study is to develop a COVID-19 vaccine hesitancy measurement instrument. Literature demonstrated a theme of seven constructs to include in the instrument: benefits, cost, confidence, convenience, complacency, risk, and perception. Face and content validity was performed using subject matter experts, self-identified COVID-19 hesitant, and non-hesitant individuals. The pilot survey data were collected from the end of December 2022 to May 2023 via an online convenient sample (n = 352). Test re-test analysis was performed 2 weeks following the initial survey (n = 73). After the test re-test and factor analysis, 29 items among two factors emerged. Factor 1 (vaccine hesitancy) includes three sub-domains (confidence, complacency, and convenience). Factor 2 (perception and trust) includes five sub-domains (perceived benefit, barrier, susceptibility, severity, and trust). This study illustrates the development of the vaccine hesitancy scale may assist policymakers and healthcare providers in the reasoning behind vaccine hesitancy towards COVID-19 vaccines. This research adds an instrument to assist public health practitioners measure COVID-19 vaccine and perception among their patient population.